Global Coronary Stent Market Report: 2010 Edition
The market for coronary stents is one of the fastest growing markets in the medical devices industry. After registering a remarkable growth from 2002 to 2006, the revenues from global coronary stents market declined thereafter. Due to the appeal for less invasive percutaneous coronary intervention procedures and advances in technology, the global coronary stents market is forecasted to grow at a CAGR of 3.7%.
Coronary artery disease is one of the leading causes of death worldwide. The treatment of coronary artery disease includes alternative treatment methodologies, that is, coronary artery bypass grafting or angioplasty (percutaneous coronary intervention) with or without stenting. The percutaneous coronary intervention procedures involving drug-eluting stents are being increasingly used to treat complex coronary artery diseases with an almost 65% penetration rate in 2009.
In the global coronary stent market, the US market for drug eluting stents is the largest market followed by Japan and China, which are also the largest markets in Asia Pacific. Collectively, the US and Japan accounted for more than half of the global drug eluting stents market in 2009. The leading coronary stent manufacturers are Boston Scientific, Johnson & Johnson/Cordis, Abbott Labs and Medtronic.
Due to the growing demand for minimally invasive procedures and the introduction of drug-eluting stents, there has been a rapid increase in the coronary stents market in the past few years. The growth in the market is being primarily driven by the increase in the elderly population, obesity rates, advances in technology, such as the emergence of bio absorbable stents and other new generation stents.
The report analyzes the coronary stent market from two perspectives. One is from the point of products, i.e., BMS and DES market size and growth rate and second is the size of the main regional stents market, like, the US, China, and Japan. It also discusses the major factors driving the market along with the new developments in the market.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Coronary artery disease is one of the leading causes of death worldwide. The treatment of coronary artery disease includes alternative treatment methodologies, that is, coronary artery bypass grafting or angioplasty (percutaneous coronary intervention) with or without stenting. The percutaneous coronary intervention procedures involving drug-eluting stents are being increasingly used to treat complex coronary artery diseases with an almost 65% penetration rate in 2009.
In the global coronary stent market, the US market for drug eluting stents is the largest market followed by Japan and China, which are also the largest markets in Asia Pacific. Collectively, the US and Japan accounted for more than half of the global drug eluting stents market in 2009. The leading coronary stent manufacturers are Boston Scientific, Johnson & Johnson/Cordis, Abbott Labs and Medtronic.
Due to the growing demand for minimally invasive procedures and the introduction of drug-eluting stents, there has been a rapid increase in the coronary stents market in the past few years. The growth in the market is being primarily driven by the increase in the elderly population, obesity rates, advances in technology, such as the emergence of bio absorbable stents and other new generation stents.
The report analyzes the coronary stent market from two perspectives. One is from the point of products, i.e., BMS and DES market size and growth rate and second is the size of the main regional stents market, like, the US, China, and Japan. It also discusses the major factors driving the market along with the new developments in the market.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. OVERVIEW
Types of Stents
Bare Metal Stents
Drug Eluting Stents
Benefits of Stenting Procedure
2. CORONARY STENT MARKET
2.1 Global Market
Market Value
PCI Procedure Growth
Penetration Rate
2.2 Regional Markets
2.2.1 United States Coronary Stent
Market Value
PCI Procedure Growth
DES Penetration Rate
2.2.2 China Coronary Stent
Market Value
PCI Procedure Growth
Market Share
2.2.3 Japan Coronary Stent
2.2.4 United Kingdom Coronary Stent
2.3 Coronary Stent Market by Stent Types
2.3.1 Bare Metal Stents
2.3.2 Drug Eluting Stents
3. MARKET DYNAMICS
3.1 Market Drivers
Smoking – A Key Driver
Obesity Rates
Elderly Population
Advances in Technology
3.2 Market Developments
Bioabsorbable Stents
Next generation Drug Eluting Stents
4. CORONARY STENT MARKET - COMPETITIVE LANDSCAPE
Global Market
US Market
5. COMPANY PROFILES
5.1 Boston Scientific
Company Overview
Key Financials
Business Strategies
Business Restructuring Initiatives
Expansion of Global Market Share
Research and Development
5.2 Cordis Corporation
Company Overview
Key Financials
Business Strategies
Developing Innovative Products
Intensifying Global Presence through Acquisitions
5.3 Abbott
Company Overview
Key Financials
Business Strategies
Realigning Manufacturing and R&D Operations
Diversification of Business
5.4 Medtronic
Company Overview
Key Financials
Business Strategies
Global Realignment Initiative
Focus on Emerging Markets for Growth
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
Types of Stents
Bare Metal Stents
Drug Eluting Stents
Benefits of Stenting Procedure
2. CORONARY STENT MARKET
2.1 Global Market
Market Value
PCI Procedure Growth
Penetration Rate
2.2 Regional Markets
2.2.1 United States Coronary Stent
Market Value
PCI Procedure Growth
DES Penetration Rate
2.2.2 China Coronary Stent
Market Value
PCI Procedure Growth
Market Share
2.2.3 Japan Coronary Stent
2.2.4 United Kingdom Coronary Stent
2.3 Coronary Stent Market by Stent Types
2.3.1 Bare Metal Stents
2.3.2 Drug Eluting Stents
3. MARKET DYNAMICS
3.1 Market Drivers
Smoking – A Key Driver
Obesity Rates
Elderly Population
Advances in Technology
3.2 Market Developments
Bioabsorbable Stents
Next generation Drug Eluting Stents
4. CORONARY STENT MARKET - COMPETITIVE LANDSCAPE
Global Market
US Market
5. COMPANY PROFILES
5.1 Boston Scientific
Company Overview
Key Financials
Business Strategies
Business Restructuring Initiatives
Expansion of Global Market Share
Research and Development
5.2 Cordis Corporation
Company Overview
Key Financials
Business Strategies
Developing Innovative Products
Intensifying Global Presence through Acquisitions
5.3 Abbott
Company Overview
Key Financials
Business Strategies
Realigning Manufacturing and R&D Operations
Diversification of Business
5.4 Medtronic
Company Overview
Key Financials
Business Strategies
Global Realignment Initiative
Focus on Emerging Markets for Growth
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
LIST OF CHARTS
Global Stent Market Revenue Growth, 2000-2009
Global PCI Procedures, 2005-2012E
Global Drug Eluting Stent Penetration Rates, Q107-Q309
US Total Stents and DES Market Size, 2005-2012E
Growth of PCI Procedures in US, 2005-2012E
US DES Penetration Rate, Q108-Q110
US Market Share of Leading Players in DES Market, 2009E
PCI Procedures in China, 2000-2012F
China DES Market Size, 2008-2014
China Market Share by Revenue, 2008
Japan’s DES Market Size, 2004-2010F
Growth of PCI Procedures Vs CABG in UK, 2000-2007
Worldwide Bare Metal Stent Sales, 1994-2011E
Worldwide Drug Eluting Stent Sales, 2002-2011E
Global Drug Eluting Stents Market Size, 2009
Market Shares of Leading Players in BMS Market, 2009E
Market Shares of Leading Players in DES Market, 2009E
Global Market Share for Different DES Players, 2008-2010E
US Market Shares for Different DES Players, 2Q09-4Q09
Sales Growth of Boston Scientific, 2005-2009
Sales Growth of Cordis, 2006-2009
Sales Growth of Abbott Labs, 2006-2009
Sales Growth of Medtronic, 2006-2009
Global Coronary Stent Market Revenue Growth, 2002-2012F
Global Stent Market Revenue Growth, 2000-2009
Global PCI Procedures, 2005-2012E
Global Drug Eluting Stent Penetration Rates, Q107-Q309
US Total Stents and DES Market Size, 2005-2012E
Growth of PCI Procedures in US, 2005-2012E
US DES Penetration Rate, Q108-Q110
US Market Share of Leading Players in DES Market, 2009E
PCI Procedures in China, 2000-2012F
China DES Market Size, 2008-2014
China Market Share by Revenue, 2008
Japan’s DES Market Size, 2004-2010F
Growth of PCI Procedures Vs CABG in UK, 2000-2007
Worldwide Bare Metal Stent Sales, 1994-2011E
Worldwide Drug Eluting Stent Sales, 2002-2011E
Global Drug Eluting Stents Market Size, 2009
Market Shares of Leading Players in BMS Market, 2009E
Market Shares of Leading Players in DES Market, 2009E
Global Market Share for Different DES Players, 2008-2010E
US Market Shares for Different DES Players, 2Q09-4Q09
Sales Growth of Boston Scientific, 2005-2009
Sales Growth of Cordis, 2006-2009
Sales Growth of Abbott Labs, 2006-2009
Sales Growth of Medtronic, 2006-2009
Global Coronary Stent Market Revenue Growth, 2002-2012F
LIST OF TABLES
Drug Eluting Stents under Development
Currently Available Drug Eluting Stents in the Market
Dependent & Independent Variables (2002– 2009)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Drug Eluting Stents under Development
Currently Available Drug Eluting Stents in the Market
Dependent & Independent Variables (2002– 2009)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
